v3.25.1

Share based payments - Summary of subscription rights outstanding and exercisable (Details) |  |  | 12 Months Ended |
--- | --- | --- | --- | ---
Oct. 01, 2024 shares | May 16, 2024 shares | Dec. 31, 2024 EquityInstruments € / shares | Dec. 31, 2023 EquityInstruments € / shares | Dec. 31, 2022 EquityInstruments € / shares | Dec. 31, 2021 EquityInstruments € / shares
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 73.19 | € 77.93 | € 83.12 | € 92.69
Outstanding at the beginning of the year |  |  | 11,472,520 | 10,816,856 | 8,579,837 |
Granted during the year | 41,000 | 1,340,000 | 1,381,000 | 1,538,400 | 3,127,239 |
Exercised during year |  |  |  | (61,560) | (282,790) |
Forfeited during the year |  |  | (547,911) | (544,676) | (607,430) |
Expired during the year |  |  | (394,500) | (276,500) |  |
Outstanding at the end of the year |  |  | 11,911,109 | 11,472,520 | 10,816,856 |
Exercisable |  |  | 5,182,941 | 5,836,538 | 2,574,218 | 1,751,013
Subscription rights |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 73.19 | € 77.93 | € 83.1 |
Outstanding at the beginning of the year |  |  | 11,472,520 | 10,816,856 |  |
Granted during the year |  |  | 1,381,000 |  |  |
Forfeited during the year |  |  | (547,911) |  |  |
Expired during the year |  |  | (394,500) |  |  |
Outstanding at the end of the year |  |  | 11,911,109 | 11,472,520 | 10,816,856 |
Exercisable |  |  | 5,182,941 |  |  |
2016 allocated on June 2016 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 46.1 |  |  |
Outstanding at the beginning of the year |  |  | 325,500 |  |  |
Expired during the year |  |  | (325,500) |  |  |
Outstanding at the end of the year |  |  |  | 325,500 |  |
2016 RMV allocated on June 2016 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 46.1 |  |  |
Outstanding at the beginning of the year |  |  | 69,000 |  |  |
Expired during the year |  |  | (69,000) |  |  |
Outstanding at the end of the year |  |  |  | 69,000 |  |
2016 (B) allocated on January 2017 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 62.5 |  |  |
Outstanding at the beginning of the year |  |  | 10,000 |  |  |
Outstanding at the end of the year |  |  | 10,000 | 10,000 |  |
Exercisable |  |  | 10,000 |  |  |
2017 allocated on May 2017 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 80.57 |  |  |
Outstanding at the beginning of the year |  |  | 585,000 |  |  |
Outstanding at the end of the year |  |  | 585,000 | 585,000 |  |
Exercisable |  |  | 585,000 |  |  |
2017 RMV allocated on May 2017 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 80.57 |  |  |
Outstanding at the beginning of the year |  |  | 122,500 |  |  |
Forfeited during the year |  |  | (17,500) |  |  |
Outstanding at the end of the year |  |  | 105,000 | 122,500 |  |
Exercisable |  |  | 105,000 |  |  |
2018 allocated on April 2018 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 79.88 |  |  |
Outstanding at the beginning of the year |  |  | 964,995 |  |  |
Forfeited during the year |  |  | (35,000) |  |  |
Outstanding at the end of the year |  |  | 929,995 | 964,995 |  |
Exercisable |  |  | 929,995 |  |  |
2018 RMV allocated on April 2018 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 79.88 |  |  |
Outstanding at the beginning of the year |  |  | 132,500 |  |  |
Forfeited during the year |  |  | (15,000) |  |  |
Outstanding at the end of the year |  |  | 117,500 | 132,500 |  |
Exercisable |  |  | 117,500 |  |  |
2019 allocated on April 2019 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 95.11 |  |  |
Outstanding at the beginning of the year |  |  | 1,208,240 |  |  |
Forfeited during the year |  |  | (63,250) |  |  |
Outstanding at the end of the year |  |  | 1,144,990 | 1,208,240 |  |
Exercisable |  |  | 1,144,990 |  |  |
2019 RMV allocated on April 2019 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 95.11 |  |  |
Outstanding at the beginning of the year |  |  | 177,250 |  |  |
Forfeited during the year |  |  | (23,750) |  |  |
Outstanding at the end of the year |  |  | 153,500 | 177,250 |  |
Exercisable |  |  | 153,500 |  |  |
2020 allocated on April 2020 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 168.42 |  |  |
Outstanding at the beginning of the year |  |  | 1,369,617 |  |  |
Forfeited during the year |  |  | (53,925) |  |  |
Outstanding at the end of the year |  |  | 1,315,692 | 1,369,617 |  |
Exercisable |  |  | 1,315,692 |  |  |
2020 RMV allocated on April 2020 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 168.42 |  |  |
Outstanding at the beginning of the year |  |  | 193,300 |  |  |
Forfeited during the year |  |  | (14,125) |  |  |
Outstanding at the end of the year |  |  | 179,175 | 193,300 |  |
Exercisable |  |  | 179,175 |  |  |
2021 BE allocated on April 2021 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 64.76 |  |  |
Outstanding at the beginning of the year |  |  | 1,032,606 |  |  |
Forfeited during the year |  |  | (17,573) |  |  |
Outstanding at the end of the year |  |  | 1,015,033 | 1,032,606 |  |
2021 RMV allocated on April 2021 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 64.76 |  |  |
Outstanding at the beginning of the year |  |  | 226,296 |  |  |
Forfeited during the year |  |  | (7,371) |  |  |
Outstanding at the end of the year |  |  | 218,925 | 226,296 |  |
Exercisable |  |  | 109,258 |  |  |
2021 ROW allocated on April 2021 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 64.76 |  |  |
Outstanding at the beginning of the year |  |  | 667,496 |  |  |
Forfeited during the year |  |  | (76,046) |  |  |
Outstanding at the end of the year |  |  | 591,450 | 667,496 |  |
Exercisable |  |  | 295,498 |  |  |
2022 (A) allocated on January 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 46.18 |  |  |
Outstanding at the beginning of the year |  |  | 30,000 |  |  |
Outstanding at the end of the year |  |  | 30,000 | 30,000 |  |
Exercisable |  |  | 15,000 |  |  |
2022 (B) allocated on January 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 50 |  |  |
Outstanding at the beginning of the year |  |  | 1,000,000 |  |  |
Outstanding at the end of the year |  |  | 1,000,000 | 1,000,000 |  |
2022 BE allocated on May 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 57.46 |  |  |
Outstanding at the beginning of the year |  |  | 817,828 |  |  |
Forfeited during the year |  |  | (13,596) |  |  |
Outstanding at the end of the year |  |  | 804,232 | 817,828 |  |
2022 BE allocated on August 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 51.58 |  |  |
Outstanding at the beginning of the year |  |  | 78,000 |  |  |
Outstanding at the end of the year |  |  | 78,000 | 78,000 |  |
2022 RMV allocated on May 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 57.46 |  |  |
Outstanding at the beginning of the year |  |  | 203,464 |  |  |
Forfeited during the year |  |  | (4,395) |  |  |
Outstanding at the end of the year |  |  | 199,069 | 203,464 |  |
Exercisable |  |  | 49,672 |  |  |
2022 ROW allocated on May 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 57.46 |  |  |
Outstanding at the beginning of the year |  |  | 705,500 |  |  |
Forfeited during the year |  |  | (74,400) |  |  |
Outstanding at the end of the year |  |  | 631,100 | 705,500 |  |
Exercisable |  |  | 157,661 |  |  |
2022 BE/ROW allocated on August 2022 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 51.58 |  |  |
Outstanding at the beginning of the year |  |  | 60,000 |  |  |
Outstanding at the end of the year |  |  | 60,000 | 60,000 |  |
Exercisable |  |  | 15,000 |  |  |
2023 BE allocated on May 2023 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 35.11 |  |  |
Outstanding at the beginning of the year |  |  | 609,028 |  |  |
Forfeited during the year |  |  | (15,778) |  |  |
Outstanding at the end of the year |  |  | 593,250 | 609,028 |  |
2023 RMV allocated on May 2023 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 35.11 |  |  |
Outstanding at the beginning of the year |  |  | 102,500 |  |  |
Forfeited during the year |  |  | (2,500) |  |  |
Outstanding at the end of the year |  |  | 100,000 | 102,500 |  |
2023 ROW allocated on May 2023 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 35.11 |  |  |
Outstanding at the beginning of the year |  |  | 561,900 |  |  |
Forfeited during the year |  |  | (65,000) |  |  |
Outstanding at the end of the year |  |  | 496,900 | 561,900 |  |
2023 BE allocated on June 2023 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 38.58 |  |  |
Outstanding at the beginning of the year |  |  | 200,000 |  |  |
Outstanding at the end of the year |  |  | 200,000 | 200,000 |  |
2023 ROW allocated on November 2023 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 32.99 |  |  |
Outstanding at the beginning of the year |  |  | 20,000 |  |  |
Outstanding at the end of the year |  |  | 20,000 | 20,000 |  |
2024 BE allocated in May 2024 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 26.9 |  |  |
Granted during the year |  |  | 679,000 |  |  |
Forfeited during the year |  |  | (11,202) |  |  |
Outstanding at the end of the year |  |  | 667,798 |  |  |
2024 RMV allocated in May 2024 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 26.9 |  |  |
Granted during the year |  |  | 21,500 |  |  |
Outstanding at the end of the year |  |  | 21,500 |  |  |
2024 ROW allocated on May 2024 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 26.9 |  |  |
Granted during the year |  |  | 639,500 |  |  |
Forfeited during the year |  |  | (37,500) |  |  |
Outstanding at the end of the year |  |  | 602,000 |  |  |
2024 BE allocated in October 2024 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 25.88 |  |  |
Granted during the year |  |  | 3,500 |  |  |
Outstanding at the end of the year |  |  | 3,500 |  |  |
2024 ROW allocated in October 2024 |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |
Exercise Price | € / shares |  |  | € 25.88 |  |  |
Granted during the year |  |  | 37,500 |  |  |
Outstanding at the end of the year |  |  | 37,500 |  |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2016AllocatedOnJune2016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2016RmvAllocatedOnJune2016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2016BAllocatedOnJanuary2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2017AllocatedOnMay2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2017RmvAllocatedOnMay2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2018AllocatedOnApril2018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2018RmvAllocatedOnApril2018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2019AllocatedOnApril2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2019RmvAllocatedOnApril2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2020AllocatedOnApril2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2020RmvAllocatedOnApril2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2021BeAllocatedOnApril2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2021RmvAllocatedOnApril2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2021RowAllocatedOnApril2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlana2022AllocatedOnJanuary2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022BAllocatedOnJanuary2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022BeAllocatedOnJune2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022BeAllocatedOnAugust2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022RmvAllocatedOnJune2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022RowAllocatedOnJune2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2022AllocatedOnJune2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2023BeAllocatedOnMay2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2023RmvAllocatedOnMay2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2023RowAllocatedOnMay2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2023BeAllocatedOnJune2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2023RowAllocatedOnNovember2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2024BeAllocatedOnMay2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2024RmvAllocatedOnMay2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2024RowAllocatedOnMay2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2024BeAllocatedOnOctober2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=glpg_SubscriptionRightPlan2024RowAllocatedOnOctober2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |